Skip to main content
Fig. 8 | Molecular Cancer

Fig. 8

From: RETRACTED ARTICLE: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Fig. 8

Tumor xenografts study of tumor growth and survival rates in nude mice. a The nude mice carrying tumors of respective groups were shown. b Sample tumors from respective group were shown. c Tumor growth curves of five groups in nude mice (n = 8). Tumor growth was monitored for up to 40 days. *P < 0.05 vs. linc00152(−)-NC + miR-103a-3p(+)-NC group, #P < 0.05 vs. linc00152(−) group, ▲P < 0.05 vs. miR-103a-3p(+) group. d Survival curves of nude mice injected into the right striatum. Mice were monitored for up to 50 days (n = 8). e The schematic cartoon of the mechanism of linc00152 as an oncogene by regulating miR-103a-3p/FEZF1/CDC25A pathway in glioma stem cells

Back to article page